Table 1

*Groups*					*Parameters*
Zileuton treated	Montelukast treated	PC	AC	NC	*Parameters*
1170.7 ± 39.96^N	1126.4 ± 34.38^N	1116.4 ± 42.9	1121.4 ± 41.6*	45.1 ± 0.94	TC (mg/dl)
358.7 ± 42.77^N	363.7 ± 37.74^N	357 ± 35.18	357.7 ± 41.3*	56 ± 1.13	TG(mg/dl)
22.7 ± 1.17^N	21.9 ± 0.8^N	22.1 ± 0.77	23 ± 1.35^N	18.1 ± 0.99	HDL(mg/dl)
1076.3 ± 41.91^N	1031.8 ± 33.89^N	1022.9 ± 38.7	1026.9 ± 37.61*	15.8 ± 1.71	LDL(mg/dl)
71.7 ± 8.55^N	72.7 ± 7.55^N	71.4 ± 7.04	71.5 ± 8.27*	11.2 ± 0.23	VLDL (mg/dl)

Results are expressed as mean ± SEM.
*p < 0.05, as compare to NC group, ^N not significant as compare to PC group

Table 1: Change in serum lipid profile among the five study groups.